These results suggest that the effect of LGG treatment on intestinal inflammation caused by estrogen deficiency may be associated with the inhibition of Th17 cell production and expression of related cytokines IL-17 and TNF-α, promotion of MLN Treg cell production, and promotion of the expression of anti-inflammatory cytokines IL-10 and TGF-β. Here, IL17A is linked to inflammation.